AstraZeneca’s Japan partner to go solo on future cancer drugs
This story seems to be about:
This story seems to be about:
Daiichi Sankyo is expanding its sales and development staff overseas, aiming to boost production capacity so that it can handle its cancer drugs business entirely ...